Improved Outcome of Allogeneic Transplantation in High-Risk Multiple Myeloma Patients After Nonmyeloablative Conditioning
Data up to Jan 2025
Total Citations Per Year
Abstract
References (22)
A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA
2013 • 2,176 citations
Allogeneic Bone Marrow Transplantation in Multiple Myeloma
1991 • 389 citations
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation
1996 • 376 citations
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
2000 • 333 citations
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study
2000 • 317 citations
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.
1995 • 301 citations
Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome
2000 • 299 citations
Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells
1999 • 253 citations
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
2001 • 196 citations
Molecular Remission After Allogeneic or Autologous Transplantation of Hematopoietic Stem Cells for Multiple Myeloma
2000 • 173 citations
Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells
2001 • 133 citations
Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease
2001 • 102 citations
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
2000 • 102 citations
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation
2000 • 67 citations
Evaluation of an Automated Technique for Assessment of Marrow Engraftment After Allogeneic Bone Marrow Transplantation Using a Commercially Available Kit
2000 • 41 citations
Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support
2000 • 26 citations
Allogeneic Haemopoietic Stem Cell Transplantation for Multiple Myeloma or Plasma Cell Leukaemia Using Fractionated Total Body Radiation and High-dose Melphalan Conditioning
2000 • 26 citations
Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma
2001 • 24 citations
Myeloma‐reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway
2001 • 19 citations
Allogeneic bone marrow transplantation for the treatment of multiple myeloma: An overview of published reports
1996 • 19 citations
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells
2000 • 13 citations
Allogeneic Peripheral Blood Stem Cell Transplantation for Hematologic Diseases
1999 • 3 citations